Sam Brusco, Associate Editor12.14.23
Abbott’s GLP systems Track laboratory automation system has earned U.S. Food and Drug Administration (FDA) approval and is now available in the U.S.
GLP systems Track touts an intelligent, self-propelled single sample carrier called CAR. Samples move independently—not attached to rigid, fixed mechanized track systems. Abbott said this reduces mechanical failures that can halt the entire system, allowing operational continuity and flexibility to change as the lab requires.
Through smart CAR technology, samples in self-propelled cars can travel throughout the track without a belt. The system helps minimize contact with patients’ blood samples an prevent exposure to biomedical waste, as well.
Abbott said GLP systems Track takes the guesswork out of sample sorting and transportation.
“We know that our customers are seeking flexibility and scalability in their laboratory operations so they can meet ever-growing demand,” said Louis Morrone, executive VP for Abbott’s core diagnostics business. “GLP systems Track addresses those needs, enabling labs to increase performance and improve the overall quality of their operations.”
The company said the automation system can handle up to 25,000 test tubes each day, boosting turnaround time for patient test results. It can also help lower operational costs and remove manual errors.
GLP systems Track isn’t approved for use in U.S. blood donor and plasma testing laboratories.
GLP systems Track touts an intelligent, self-propelled single sample carrier called CAR. Samples move independently—not attached to rigid, fixed mechanized track systems. Abbott said this reduces mechanical failures that can halt the entire system, allowing operational continuity and flexibility to change as the lab requires.
Through smart CAR technology, samples in self-propelled cars can travel throughout the track without a belt. The system helps minimize contact with patients’ blood samples an prevent exposure to biomedical waste, as well.
Abbott said GLP systems Track takes the guesswork out of sample sorting and transportation.
“We know that our customers are seeking flexibility and scalability in their laboratory operations so they can meet ever-growing demand,” said Louis Morrone, executive VP for Abbott’s core diagnostics business. “GLP systems Track addresses those needs, enabling labs to increase performance and improve the overall quality of their operations.”
The company said the automation system can handle up to 25,000 test tubes each day, boosting turnaround time for patient test results. It can also help lower operational costs and remove manual errors.
GLP systems Track isn’t approved for use in U.S. blood donor and plasma testing laboratories.